Pharmacotherapy in post -industry rehabilitation

Authors

Gnedovskaya E.V. , Lukmanov R.Kh. , Rimkevichus A.A. , Suponeva N.A.

The existing methods of pharmacotherapy in the recovery period of a stroke used to correct motor, affective and cognitive disorders were carried out. Data on the conditions for the use and effectiveness of botulinum toxin, oral muscle relaxants, selective reversal inhibitors of serotonin, acetylcholinestin inhibitors and a glutamatergic transmission in post -stroke neurorebilitation, recommendations for their rational and safe use are given.
The clinical effectiveness of Mexidol, which has a multimodal effect on a wide range of post -stroke disorders, especially with prolonged consistent therapy, was discussed The integrated use of post -industry rehabilitation agents with the determination of individual tactics on the basis of the clinical picture of the patient and the established rehabilitation goals has been recommended. To solve problems associated with improving motor, cognitive and affective functions, as well as self -care and quality of life, the inclusion of Mexidol in the complex therapy of patients with the consequences of a stroke looks promising. A continuation of high -quality clinical studies is required to assess the effectiveness of pharmacological agents regarding post -industry disorders.

Key words: stroke, hemiparesis, spasticity, depression, dementia, neurorebilitation, pharmacotherapy.